Republican Senators Marsha Blackburn and Martha McSally have introduced legislation that would allow U.S. citizens to file lawsuits against the Chinese Communist Party over the COVID-19 pandemic.

The senators are calling it the Stop COVID Act, with "COVID" standing for "China-Originated Viral Infectious Diseases."

"This would allow the insertion of COVID-19 as a 'biological agent,'" Blackburn said, adding the change would be made to the Foreign Sovereign Immunities Act.

As precedent, Blackburn pointed out that the law allowed families of the victims of the 9/11 attacks to sue Saudi Arabia for its suspected role in those attacks.

"What we are doing is giving the individual citizen the right to hold the Chinese Communist Party legally responsible for the act that they have committed," Blackburn said.

During the interview Tuesday, the senator would not rule out speculation the coronavirus that has spread across the globe was a man-made biological weapon, despite a lack of evidence.

"We're going to leave it to the intel community and Five Eyes to say exactly what happened here," the Tennessee senator said. "[China] had 3,000 cases on their hands before they said anything about this."

The theory that the coronavirus emerged from a lab in China has pitted medical experts, like Dr. Anthony Fauci, against senior Trump administration officials. Secretary of State Mike Pompeo said there was "enormous evidence" to support the theory in an interview on ABC News earlier this month, though he also said he had "no reason to disbelieve" the Office of the Director of National Intelligence assessment that "the COVID-19 virus was not manmade or genetically modified."  

Blackburn, who has publically shared Pompeo's view, says that whether the coronavirus was manmade, the Chinese government failed to protect its citizens and the rest of the world.

"They eliminated travel between Wuhan and the rest of China, but they allowed international flights from Wuhan to other parts of the globe," Blackburn said. "They knew about this for weeks. They didn't do anything to stop it."

Share:
More In Politics
Trump suggests canceling Xi meeting and threatens more tariffs after China restricts key exports
President Donald Trump says “there seems to be no reason” to meet with Chinese leader Xi Jinping as part of an upcoming trip to South Korea after China restricted exports of rare earths needed for American industry. The Republican president suggested Friday he was looking at a “massive increase” of import taxes on Chinese products in response to Xi’s moves. Trump says one of the policies the U.S. is calculating is "a massive increase of Tariffs on Chinese products coming into the United States." A monthslong calm on Wall Street was shattered, with U.S. stocks falling on the news. The Chinese Embassy in Washington hasn't responded to an Associated Press request for comment.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More